Stock Analysis

Mehadrin (TLV:MEDN) Is Carrying A Fair Bit Of Debt

TASE:MEDN
Source: Shutterstock

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. Importantly, Mehadrin Ltd (TLV:MEDN) does carry debt. But should shareholders be worried about its use of debt?

When Is Debt Dangerous?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. If things get really bad, the lenders can take control of the business. However, a more common (but still painful) scenario is that it has to raise new equity capital at a low price, thus permanently diluting shareholders. Of course, the upside of debt is that it often represents cheap capital, especially when it replaces dilution in a company with the ability to reinvest at high rates of return. When we think about a company's use of debt, we first look at cash and debt together.

Check out our latest analysis for Mehadrin

How Much Debt Does Mehadrin Carry?

You can click the graphic below for the historical numbers, but it shows that as of March 2023 Mehadrin had ₪331.5m of debt, an increase on ₪299.6m, over one year. However, it also had ₪160.0m in cash, and so its net debt is ₪171.5m.

debt-equity-history-analysis
TASE:MEDN Debt to Equity History July 18th 2023

How Strong Is Mehadrin's Balance Sheet?

The latest balance sheet data shows that Mehadrin had liabilities of ₪606.8m due within a year, and liabilities of ₪144.7m falling due after that. On the other hand, it had cash of ₪160.0m and ₪427.2m worth of receivables due within a year. So its liabilities total ₪164.3m more than the combination of its cash and short-term receivables.

Mehadrin has a market capitalization of ₪482.4m, so it could very likely raise cash to ameliorate its balance sheet, if the need arose. But it's clear that we should definitely closely examine whether it can manage its debt without dilution. There's no doubt that we learn most about debt from the balance sheet. But you can't view debt in total isolation; since Mehadrin will need earnings to service that debt. So if you're keen to discover more about its earnings, it might be worth checking out this graph of its long term earnings trend.

In the last year Mehadrin wasn't profitable at an EBIT level, but managed to grow its revenue by 6.1%, to ₪1.1b. We usually like to see faster growth from unprofitable companies, but each to their own.

Caveat Emptor

Over the last twelve months Mehadrin produced an earnings before interest and tax (EBIT) loss. Its EBIT loss was a whopping ₪90m. Considering that alongside the liabilities mentioned above does not give us much confidence that company should be using so much debt. So we think its balance sheet is a little strained, though not beyond repair. However, it doesn't help that it burned through ₪35m of cash over the last year. So in short it's a really risky stock. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. Case in point: We've spotted 1 warning sign for Mehadrin you should be aware of.

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

Valuation is complex, but we're helping make it simple.

Find out whether Mehadrin is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.